Dr. J. Joseph Kim, CEO at Inovio Pharmaceuticals, discusses vaccine development for COVID-19. Kim points out that there's been "a lot of incremental successes" in phase one trials. He also talks about the importance of ensuring safety and efficacy.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Investing Trends and Worries at Future Proof in California
39:49

NYC's Lincoln Center Aims To Bring World Class Art To Everyone
11:25

Global AI Supercycle Raises Productivity Questions
41:36